Table 3. Univariate and multivariate analysis of factors associated with recurrence-free survival.
Variables | Univariate | Multivariate | |||
---|---|---|---|---|---|
Hazard ratio | P | Hazard ratio | 95% CI | P | |
NLR | 0.008 | 0.07 | |||
Low NLR (≤1.7) High NLR (>1.7) |
1 1.446 |
1 1.319 |
0.978-5.087 | ||
LMR Low LMR (≤6.8) High LMR (>6.8) |
1 0.53 |
0.008 | 1 0.658 |
0.405-1.070 | 0.092 |
PLR Low PLR (≤92.88) High PLR (>92.88) |
1 0.765 |
0.076 | 1 0.649 |
0.473-0.89 | 0.007 |
ypT stage | <0.001 | <0.001 | |||
ypT0 | 1 | 1 | |||
ypT1 ypT2 ypT3 ypT4 |
0.388 1.852 5.216 6.235 |
0.417 1.694 3.297 3.208 |
0.097-1.799 0.972-1.449 1.980-5.491 0.74-14.7 |
||
ypN stage ypN0 ypN1 ypN2 |
1 2.931 5.347 |
<0.001 | 1 1.882 2.345 |
1.385-2.557 1.538-3.575 |
<0.001 |
Lymphovascular invasion | 3.637 | <0.001 | 1.762 | 1.229-2.526 | 0.002 |
Perineural invasion | 3.195 | <0.001 | 1.509 | 1.093-2.083 | 0.012 |
Age, yrs ≤70 >70 |
1 1.09 |
0.648 | |||
Gender Male Female |
1 0.893 |
0.431 |
NLR, neutrophil to lymphocyte ratio; LMR, lymphocyte to monocyte ratio; PLR, platelet to lymphocyte ratio